People who took Pfizer’s antiviral treatment Paxlovid shortly after infection saw a 26% lower risk of long Covid compared with those who didn’t, the study said.
You are here: Home / Pfizer’s Covid drug Paxlovid may reduce the risk of developing long Covid, study says